Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014989
Filing Date
2025-05-30
Accepted
2025-05-30 16:16:55
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 form4-05302025_080545.html 4  
1 form4-05302025_080545.xml 4 4108
  Complete submission text file 0001415889-25-014989.txt   5478
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 835 S PARK AVE HINSDALE IL 60521
Business Address
Myers Kristin (Reporting) CIK: 0002018445 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 251011177